ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology.

Feldhaus, Andrew L

ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology. [electronic resource] - Endocrinology 01 2017 - 1-8 p. digital

Publication Type: Journal Article

1945-7170

10.1210/en.2016-1455 doi


Adrenal Hyperplasia, Congenital--drug therapy
Adrenocorticotropic Hormone--antagonists & inhibitors
Animals
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
CHO Cells
Corticosterone--blood
Cricetinae
Cricetulus
Drug Evaluation, Preclinical
Humans
Hydrocortisone--blood
Macaca fascicularis
Male
Pituitary ACTH Hypersecretion--drug therapy
Rabbits
Rats
Rats, Inbred Lew
Receptor, Melanocortin, Type 2--metabolism
Stress, Psychological--blood